We are live on ! Find out more
EPZM

Epizyme, Inc
EPZM

Delisted

EPZM was delisted on the 11th of August, 2022.

Back to rankings

101 hedge funds and large institutions have $749M invested in Epizyme, Inc in 2017 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 40 increasing their positions, 27 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

96% more call options, than puts

Call options by funds: $2.27M | Put options by funds: $1.16M

48% more repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 27

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

3% less funds holding

Funds holding: 104 → 101 (-3)

12% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 17

35% less capital invested

Capital invested by funds: $1.15B → $749M (-$402M)

Holders
101
Holders Change
-3
Holders Change %
-2.88%
% of All Funds
2.29%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
15
Increased
40
Reduced
27
Closed
17
Calls
$2.27M
Puts
$1.16M
Net Calls
+$1.11M
Net Calls Change
-$673K

Top Buyers

Rank Fund Capital Flow
1
RG
Redmile Group
California
+$10.4M
2
BlackRock
BlackRock
New York
+$8.43M
3
PCM
Peregrine Capital Management
Minnesota
+$7.27M
4
PAI
Palo Alto Investors
California
+$6.72M
5
State Street
State Street
Massachusetts
+$6.26M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$38.3M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$11.7M
3
EAM
Eventide Asset Management
Massachusetts
-$5.24M
4
Invesco
Invesco
Georgia
-$4.98M
5
LCM
Laurion Capital Management
New York
-$4.53M
Name Holding Trade Value Shares
Change 		Change in
Stake
Deutsche Bank
26
Deutsche Bank
Germany
$3.39M -$281K -19,298 -7%
Charles Schwab
27
Charles Schwab
California
$3.08M +$416K +28,588 +13%
BBA
28
Baker Bros. Advisors
New York
$2.92M – – –
RPAM
29
Rhenman & Partners Asset Management
Sweden
$2.73M -$272K -18,702 -8%
Bank of New York Mellon
30
Bank of New York Mellon
New York
$2.67M +$157K +10,805 +5%
UONDDL
31
University of Notre Dame du Lac
Indiana
$2.57M +$187K +12,881 +7%
PP
32
PDT Partners
New York
$1.97M +$2.28M +156,700 New
Renaissance Technologies
33
Renaissance Technologies
New York
$1.95M -$1.09M -75,112 -33%
California Public Employees Retirement System
34
California Public Employees Retirement System
California
$1.7M – – –
Goldman Sachs
35
Goldman Sachs
New York
$1.66M -$1.36M -93,592 -41%
Hudson Bay Capital Management
36
Hudson Bay Capital Management
Connecticut
$1.57M +$1.82M +125,000 New
Point72 Asset Management
37
Point72 Asset Management
Connecticut
$1.51M -$11.7M -803,400 -87%
TCIM
38
TIAA CREF Investment Management
New York
$1.42M +$41.2K +2,832 +3%
Morgan Stanley
39
Morgan Stanley
New York
$1.39M +$197K +13,521 +14%
TA
40
Teachers Advisors
New York
$1.1M +$179K +12,281 +16%
QI
41
QS Investors
New York
$1.1M -$70.7K -4,866 -5%
Swiss National Bank
42
Swiss National Bank
Switzerland
$1.05M – – –
Macquarie Group
43
Macquarie Group
Australia
$1.03M +$602K +41,385 +101%
California State Teachers Retirement System (CalSTRS)
44
California State Teachers Retirement System (CalSTRS)
California
$969K +$159K +10,970 +17%
AA
45
ALPS Advisors
Colorado
$964K +$281K +19,301 +34%
CS
46
Credit Suisse
Switzerland
$930K +$135K +9,260 +14%
SCA
47
Secor Capital Advisors
New York
$927K +$57.8K +3,978 +6%
Citigroup
48
Citigroup
New York
$864K +$472K +32,493 +89%
Invesco
49
Invesco
Georgia
$787K -$4.98M -342,803 -85%
LCM
50
Landscape Capital Management
New Jersey
$641K +$742K +51,077 New
1
2
3 4 5

EPZM Hedge Fund Activity: Q4 2017 in Review

101 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Epizyme, Inc (EPZM) for Q4 2017, worth a combined $749M — down 35% from $1.15B a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of EPZM and 15 opened new positions — a net loss of 2 holders — while 27 trimmed existing stakes and 40 added.

The largest buyer was Redmile Group, adding an estimated $10.4M. The largest seller was Fidelity Investments, cutting an estimated $38.3M.

  • 101 institutional investors held Epizyme, Inc (EPZM) as of Q4 2017, down from 104 in Q3 2017.
  • Funds reported $749M of Epizyme, Inc stock for Q4 2017, down 35% quarter-over-quarter.
  • 15 funds opened new Epizyme, Inc positions in Q4 2017 and 17 closed out, a net change of -2 holders.
  • The largest Epizyme, Inc buyer in Q4 2017 was Redmile Group, an estimated $10.4M added.
  • The largest Epizyme, Inc seller in Q4 2017 was Fidelity Investments, an estimated $38.3M sold.

Based on aggregated 13F filings for Q4 2017.